tradmap

LRCX Financials Lam Research

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 9.7% per year over the past 5 years.
  • Net income has grown faster than revenue (13.2% vs 9.7% per year).
  • Operating margin has expanded, at 35.3% in the latest year.
  • Free cash flow has grown 8.6% per year over the past 5 years.

Financial health

  • The company holds more cash ($5.6B) than total debt ($3.7B).
  • Total debt has grown slower than revenue (-5.6% vs 9.7% per year).
  • Operating income covered interest expense 52× in the latest year.
  • Total debt is 0.4× EBITDA.

Shareholder returns

  • Dividends have been paid for 12 consecutive years, consuming 17.5% of earnings and 26.0% of free cash flow.
  • The dividend has grown 11.8% per year over the past 5 years.
Revenue & net income
$0 $12B $23B 2012 2014 2016 2018 2020 2022 2024 2026
RevenueNet income
Margins (gross / operating / net)
0% 25% 50% 2012 2014 2016 2018 2020 2022 2024 2026
GrossOperatingNet
Return on equity & assets (ROE / ROA)
0% 37% 73% 2012 2014 2016 2018 2020 2022 2024 2026
ROEROA
Free cash flow (CFO − capex)
$0 $3B $5B 2012 2014 2016 2018 2020 2022 2024 2026
Free cash flow
Cash vs total debt
$0 $3B $6B 2012 2014 2016 2018 2020 2022 2024 2026
CashTotal debt
Cash flow: operating / investing / financing
-$6B $228M $6B $0 2012 2014 2016 2018 2020 2022 2024 2026
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2026 $23.2B $7.3B 50.5% 35.3% 58.3% 30.9% $4.9B $3.7B $5.6B
2025 $18.4B $5.4B 48.7% 32.0% 54.3% 25.1% $5.4B $4.5B $6.4B
2024 $14.9B $3.8B 47.3% 28.6% 44.8% 20.4% $4.3B $5.0B $5.8B
2023 $17.4B $4.5B 44.6% 29.7% 54.9% 24.0% $4.7B $5.0B $5.3B
2022 $17.2B $4.6B 45.7% 31.2% 73.4% 26.8% $2.6B $5.0B $3.5B
2021 $14.6B $3.9B 46.5% 30.6% 64.8% 24.6% $3.2B $5.0B $4.4B
2020 $10.0B $2.3B 45.9% 26.6% 43.5% 15.5% $1.9B $5.8B $4.9B
2019 $9.7B $2.2B 45.1% 25.5% 46.9% 18.3% $2.9B $4.4B $3.7B
2018 $11.1B $2.4B 46.6% 29.0% 36.6% 19.1% $2.4B $2.4B $4.5B
2017 $8.0B $1.7B 45.0% 23.7% 24.9% 14.0% $1.9B $2.7B $2.4B
2016 $914M 15.5% 7.5% $4.3B $5.0B
2015 $656M 12.8% 7.0% $2.4B $1.5B
2014 $632M 12.6% 7.9% $1.3B $1.5B
2013 $114M 2.5% 1.6% $559M $1.3B $1.2B
2012 $169M 3.3% 2.1% $392M $1.3B $1.6B

Valuation over time

How the market has priced LRCX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 147.7 295.3 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 38.2 76.4 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S
Dividend yield (%)
0.0 0.6 1.1 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
Dividend yield %

Frequently asked questions

Is LRCX growing its revenue and profit?

Over the past 5 years, Lam Research's revenue has grown 9.7% per year, and net income grown 13.2% per year. These are computed facts, not advice.

How much debt does LRCX have?

As of FY2026, Lam Research reported $3.7B of total debt against $5.6B of cash; operating income covered interest expense 52×.

What is LRCX's profit margin?

In FY2026, gross margin was 50.5%, operating margin 35.3%, and net margin 31.3%.

What is LRCX's P/E ratio?

As of Sep '26, Lam Research traded at a price-to-earnings ratio of about 50.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.